Supportive Care in Cancer最新文献

{"title":"The risk factors influencing nonroutine discharge in surgical patients with spinal metastases: a scoping review.","authors":"Kai-Yan Fan, Jian-Li Lu, Meng-Wen Wu, Ke-Zhen Zhou, Li-Li Jin","doi":"10.1007/s00520-025-09481-y","DOIUrl":"https://doi.org/10.1007/s00520-025-09481-y","url":null,"abstract":"<p><strong>Purpose: </strong>Nonroutine discharge is associated with increased healthcare costs and higher readmission rates among surgical patients with spinal metastases. However, the factors influencing nonroutine discharge remain inadequately summarized, and related research is still in its early stages. This review aims to identify and analyze the risk factors associated with nonroutine discharge in these patients, with the goal of informing discharge planning.</p><p><strong>Methods: </strong>A scoping review was conducted following the framework established by Arksey and O'Malley. We systematically searched PubMed, Web of Science, and CINAHL for studies examining risk factors influencing nonroutine discharge in surgical patients with spinal metastases. Data extraction was performed independently by two researchers, with discrepancies resolved by a third reviewer.</p><p><strong>Results: </strong>Nine studies were included, which identified a range of factors influencing nonroutine discharge. These factors were categorized into three main domains: (1) sociodemographic factors (age, race, insurance status, marital status, and family member involvement), (2) disease-related factors (spinal cord injury grade, serum albumin level, body mass index, spinal surgery segment, type of surgery, preoperative functional dependency, ASA grade, emergency versus elective surgery, and activities of daily living at discharge), and (3) other factors (frailty index, comorbidity index, and the efficiency of the referral or discharge process).</p><p><strong>Conclusion: </strong>The risk of nonroutine discharge in surgical patients with spinal metastases is influenced by sociodemographic, disease-related, and other factors. Early identification of patients at risk for nonroutine discharge is crucial for implementing a comprehensive, nurse-led discharge plan aimed at reducing hospital stay duration and minimizing related complications.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 5","pages":"424"},"PeriodicalIF":2.8,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144047118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring the impact of breast cancer support groups on survivorship and treatment decision-making in eastern Ethiopia: a qualitative study.","authors":"Nahom G Belete, Meera Bhakta, Tara Wilfong, Mahlet Shewangizaw, Edilawit Abebaw Abera, Yehenaw Tenaw, Michael Shawel, Habtamu Seife, Biruk Habtamu, Nahom Wondwossen, Elizabeth A Wood","doi":"10.1007/s00520-025-09475-w","DOIUrl":"10.1007/s00520-025-09475-w","url":null,"abstract":"<p><strong>Purpose: </strong>This study explores the psychosocial impact of breast cancer (BC) support groups on survivorship and treatment decision-making among women in Harar, Ethiopia. It examines the influence of cultural, social, and economic factors on treatment decisions and assesses the effectiveness of support groups in addressing these challenges.</p><p><strong>Methods: </strong>A community-based case study used semi-structured, in-depth interviews and focus group discussions. Participants included women attending BC support groups and key informants, including healthcare providers, caregivers, and spiritual leaders. Data were collected at the Hiwot Fana Cancer Treatment Center and were analyzed thematically using an inductive approach to identify key themes.</p><p><strong>Results: </strong>The study highlighted significant barriers to timely BC treatment, including cultural stigma, financial constraints, reliance on alternative medicine, and limited healthcare infrastructure. Support groups were pivotal in improving emotional and psychological well-being, fostering a sense of community, and influencing treatment decision-making. Participants reported increased awareness, reduced stigma, and enhanced community advocacy.</p><p><strong>Conclusions: </strong>BC support groups in Harar address critical gaps in cancer care by providing psychosocial support and mitigating barriers to treatment. These groups also serve as platforms for community education and advocacy, promoting early detection and modern treatment practices.</p><p><strong>Implications for cancer survivors: </strong>Support groups empower BC survivors by improving emotional resilience, facilitating informed treatment decisions, and fostering a sense of belonging. They also help reduce stigma and build supportive community networks essential for long-term survivorship in low-resource settings. Expanding access to such groups could significantly enhance cancer care outcomes in Ethiopia and similar contexts.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 5","pages":"419"},"PeriodicalIF":2.8,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12031865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144019525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incidence and management of diarrhoea associated with abemaciclib and endocrine therapy for hormone-receptor positive, HER2-negative metastatic breast cancer: the UK patients' experiences.","authors":"Helena Harder, Rachel Starkings, Lesley Fallowfield, Shirley May, Valerie Shilling","doi":"10.1007/s00520-025-09440-7","DOIUrl":"https://doi.org/10.1007/s00520-025-09440-7","url":null,"abstract":"<p><strong>Purpose: </strong>Addition of a CDK4/6 inhibitor to endocrine therapy (ET) prolongs survival in HR + /HER2-metastatic breast cancer (MBC). Gastrointestinal side effects, predominantly diarrhoea and abdominal pain, are common in patients receiving abemaciclib. This can potentially increase symptom burden, reduce quality of life (QoL) and affect treatment adherence. This longitudinal mixed-methods study with a 6-month follow-up explored patients' outcomes and experiences.</p><p><strong>Methods: </strong>Participants (n = 44) completed validated QoL measures at study-entry and at 1, 3 and 6 months. Weekly diarrhoea diaries with free-text response options assessed bowel movements and self-management strategies. Optional interviews gathered insight in patients' experiences.</p><p><strong>Results: </strong>Forty-two participants completed study measures at study-entry and 24 at 6 months. 17/42 reported no gastrointestinal side-effects. Above threshold diarrhoea (≥ 3 loose/liquid stools daily) was reported at least once by 25/42, with 3/42 having persistent symptoms. Strategies to control diarrhoea, employed by 28/42, included dietary modifications, non-prescribed medication-use and nonadherence (dose interruption or reduction). Meaningful decline on the QoL diarrhoea subscale was observed in 12/37 at 1 month, 13/28 at 3 months and 8/23 at 6 months. Free-text analysis showed that diarrhoea disrupted everyday life in those affected.</p><p><strong>Conclusion: </strong>A proportion of this small sample of MBC patients treated with abemaciclib and ET-reported diarrhoea which affected symptom burden and QoL. Close symptom monitoring alongside targeted supportive/educational interventions should be introduced to reduce the negative impact on patients' lives.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov Identifier: ISRCTN17281696.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 5","pages":"422"},"PeriodicalIF":2.8,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12033210/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144047718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Use of NCCN distress thermometer in cancer genetics patients.","authors":"Aidan M Kennedy, Andrea M Murad, Erika S Koeppe, Michelle B Riba, Elena M Stoffel, Michelle F Jacobs","doi":"10.1007/s00520-025-09473-y","DOIUrl":"https://doi.org/10.1007/s00520-025-09473-y","url":null,"abstract":"<p><strong>Purpose: </strong>Distress is not routinely measured in patients undergoing cancer genetic counseling. We evaluated the use of the National Comprehensive Cancer Network® (NCCN®) Distress Thermometer (DT) and Problem List (PL) in an unselected population of individuals presenting to a cancer genetics clinic to determine their utility in assessing distress in this population.</p><p><strong>Methods: </strong>Patients presenting to one cancer genetics clinic between April 2019 and March 2020 were asked to complete the DT and PL (2019 version). New patients aged 18 or older were divided into categories of low (DT score < 4) and high distress (DT score ≥ 4), consistent with NCCN groupings for evaluation of distress. Correlates of distress were explored using Chi-square and t tests.</p><p><strong>Results: </strong>Younger age and female sex assigned at birth were associated with reporting high distress. Personal history of cancer was not associated with high distress. Worry, fatigue, and sleep disturbance were the most commonly patient-reported problems.</p><p><strong>Conclusion: </strong>Findings from this study show that the DT can assist in identifying patients undergoing cancer genetic counseling who are experiencing high distress; however, research to develop a PL more specific to the concerns of the oncology genetic counseling patient population may be considered to better identify relevant patient problems.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 5","pages":"423"},"PeriodicalIF":2.8,"publicationDate":"2025-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12033117/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144054476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence and impact of financial toxicity in older patients with cancer: a prospective observational study in India.","authors":"Vanita Noronha, Arnav Tongaonkar, Anupa Pillai, Abhijith Rajaram Rao, Anita Kumar, Arshiya Sehgal, Renee Basu, Anant Ramaswamy, Ratan Dhekale, Anuradha Daptardar, Lekhika Sonkusare, Manjusha Vagal, Purabi Mahajan, Manjunath Nookala, Ankita Chitre, Vikram Gota, Oindrila Roy Chowdhury, Ankush Shetake, Aruni Ghose, Shripad Banavali, Rajendra Badwe, Kumar Prabhash","doi":"10.1007/s00520-025-09252-9","DOIUrl":"10.1007/s00520-025-09252-9","url":null,"abstract":"<p><strong>Purpose: </strong>We aimed to assess the prevalence of financial toxicity in older Indian patients with cancer and evaluate the association with quality of life (QoL), distress, vulnerabilities in the geriatric assessment, and factors impacting financial toxicity.</p><p><strong>Methods: </strong>This was a prospective observational study at the Tata Memorial Center (Mumbai, India) in patients aged 60 years and over, planned for cancer-directed therapy. We used the COST-FACIT and CFPB Financial Well-Being Scales to assess financial toxicity. QoL was assessed with the European Organization for Research and Treatment of Cancer (EORTC) QLQ C30 questionnaire, and distress with the NCCN distress thermometer.</p><p><strong>Results: </strong>Between June 2022 and September 2023, we enrolled 953 patients. The median age was 66 (IQR 63-72) years; 277 patients (29.1%) were over 70 years old, 737 (77.3%) were male, and 135 (14.2%) had health insurance. Therapy was planned with palliative intent in 607 (63.7%) patients. The prevalence of financial toxicity was 73.7% as per the COST-FACIT scale (n = 703), and 66% as per the CFPB (n = 629). Higher financial toxicity on the COST-FACIT scale was associated with poor financial well-being on the CFPB scale. Financial toxicity was associated with poor QoL and higher distress. Factors associated with significantly greater financial toxicity included history of tobacco chewing, monthly family income less than ₹50,000, lack of health insurance, illiteracy, depression, and cognitive impairment.</p><p><strong>Conclusions: </strong>Identifying the factors contributing to financial toxicity will help make the cancer treatment journey smoother, more accessible and improve compliance to therapy for older patients.</p><p><strong>Clinical trial registration: </strong>ClinicalTrials.gov Identifier: CTRI/2020/04/024675.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 5","pages":"416"},"PeriodicalIF":2.8,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12031899/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144019723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Investigation of the reasons and frequency of oncology patients over the age of 65 who apply to the emergency department.","authors":"Nedime Hazal Döner, Öznur Usta Yeşilbalkan, Uğur Taktuk","doi":"10.1007/s00520-025-09462-1","DOIUrl":"https://doi.org/10.1007/s00520-025-09462-1","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to investigate frequency and causes of emergency department visits among oncology patients aged 65 and older.</p><p><strong>Method: </strong>In this cross-sectional, descriptive and comparative study, data were collected a questionnaire form from a single emergency deparment of a university hospital in İzmir, West Turkey between January 2022 and July 2022. Data were analyzed by using IBM SPSS Statistics 25 software.</p><p><strong>Results: </strong>A total 125 patients were included in the study. The most common causes of patients to the emergency derparment were infection, pain, nausea-vomiting, and dyspnea. A significant difference was found between the reason for the patient's emergency department visit and their knowledge of when to seek medical help (p < 0.05).</p><p><strong>Conclusion: </strong>The recurrent visits of cancer patients to emergency departments suggest an inadequacy of comprehensive information available to both patients and their caregivers concerning the pursuit of emergency medical intervention.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 5","pages":"414"},"PeriodicalIF":2.8,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12031836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144064598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"\"Returning beyond cancer\"-a journey of professional reinvention for nurses.","authors":"Qingyi Xue, Wenjing Xu, Xulu Wang, Xiaojing Ye, Wanting Hong, Qianqian Chen, Xin Lu, Xiaolei Wang, Chunmei Zhang","doi":"10.1007/s00520-025-09467-w","DOIUrl":"https://doi.org/10.1007/s00520-025-09467-w","url":null,"abstract":"<p><strong>Purpose: </strong>Nurse cancer survivors (NCSs) face significant challenges in adapting to returning to work (RTW) and require special attention and support. Little is known about the meaning NCSs attribute to their work, the changes in their personal feelings, and their needs in coping with these changes after RTW. This interpretive phenomenological study aimed to explore NCSs' feelings and experiences after RTW in greater depth to help improve their quality of working life (QWL).</p><p><strong>Methods: </strong>Semi-structured interviews were conducted with 15 NCSs in China between March 2023 and August 2023. The transcripts were analyzed using interpretative phenomenological analysis (IPA).</p><p><strong>Results: </strong>The data was categorized into four themes: (1) psychological odyssey, (2) accessing social support, (3) benefiting from professional background, and (4) realization of professional values.</p><p><strong>Conclusion: </strong>This study uses IPA to explore the work experiences of NCSs and ways to improve their QWL. It is recommended that managers pay attention to the psychology of their RTW, enhance support, encourage the use of professional strengths, and value their insights and professional development.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 5","pages":"417"},"PeriodicalIF":2.8,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143998423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comment on \"A systematic review and meta‑analysis of side effects influenced by non‑surgical treatments in African cancer patients\".","authors":"Venkata Dileep Kumar Veldi, Rachana Mehta, Ranjana Sah","doi":"10.1007/s00520-025-09487-6","DOIUrl":"10.1007/s00520-025-09487-6","url":null,"abstract":"","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 5","pages":"415"},"PeriodicalIF":2.8,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144047715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Optimizing post-acute care inpatient rehabilitation for patients with brain metastasis: A systematic review of functional outcomes.","authors":"Brianna M Donnelly, Katherine G Stark, Cameron J Persaud, Randy S D'Amico, Chanel I Davidoff","doi":"10.1007/s00520-025-09468-9","DOIUrl":"https://doi.org/10.1007/s00520-025-09468-9","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to provide insight into optimizing inpatient rehabilitation (IR) for patients with brain metastases (BM) following hospitalization, including exploring functional outcomes and reviewing interdisciplinary considerations.</p><p><strong>Methods: </strong>Using PRISMA guidelines, a search of PubMed and Embase was conducted to identify studies demonstrating functional outcomes of IR for patients with brain metastases.</p><p><strong>Results: </strong>Three studies met inclusion criteria and a total of 59 patients with brain metastasis underwent IR. The median length of IR was 19.2 days (range: 17.95 - 20). Discharge destination after IR is available for 39 patients, including 33 (84.6%) who were discharged home, 1 (2.6%) who was discharged to a long-term care facility, 3 (7.7%) to an acute care ward, and 2 (5.1%) to palliative care. All 3 studies (n=59) used the Functional Independence Measure (FIM) to assess function after IR. The weighted average total FIM percent gain between admission and discharge was 14.9% (range: 9.6% - 27.4%) and the average FIM efficiency was 0.61 (range: 0.45 - 0.94). For the 2 studies (n=46) that reported motor and cognitive FIM, the weighted average motor gain (16.5%) was greater than the cognitive gain (3.6%).</p><p><strong>Conclusion: </strong>Inpatient rehabilitation (IR) may enhance functional status and independence in patients with brain metastases during the interim post-hospitalization period, optimizing functional performance for a smoother transition to subsequent oncologic treatments. Healthcare providers within the multidisciplinary team should optimize the post-acute hospitalization period by considering both functional status and oncologic prognosis in patients with brain metastases to streamline rehabilitation efforts and minimize delays in oncologic care.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 5","pages":"418"},"PeriodicalIF":2.8,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144000191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"International survey on training of dermatology residents in supportive oncodermatology: the RESCUE study.","authors":"Ariadna Ortiz-Brugués, Davide Fattore, Marie Boileau, Ana-Maria Forsea, Zoe Apalla, Vasiliki Nikolaou, Tatjana Radević, Jelena Stojkovic-Filipovic, Azael Freites-Martinez, Grazyna Kaminska-Winciorek, Yannick Elshot, Eszter Baltas, Ana-Clara Torre, Julia Riganti, Milan Anadkat, Alexander Bang, Monika Fida, Bertrand Richert, Lukas Kraehenbuehl, Emily Avitan, Nuno-Miguel Preto-Gomes, Jessica C Hassel, Brent J Doolan, Nicolas Kluger, Cécile Pagès, Benoit Guillon, Noémie Lacroix, Mario Lacouture, Vincent Sibaud","doi":"10.1007/s00520-025-09459-w","DOIUrl":"https://doi.org/10.1007/s00520-025-09459-w","url":null,"abstract":"<p><strong>Purpose: </strong>The dermatological management of cancer patients with cutaneous adverse events occurring during and after oncologic treatment is known as supportive oncodermatology. This includes prevention, early identification, and mitigation of dermatologic toxicities. The aim of the international RESCUE (Residents' survey on training of dermatology residents in supportive oncodermatology) study was to ascertain the current level of expertise in supportive oncodermatology among dermatology residents.</p><p><strong>Methods: </strong>The European Task Force \"Dermatology for cancer patients\" and the US Oncodermatology Society developed an online questionnaire with 30 multiple-choice items. Responses were collected using qualitative ordinal data (yes/no, 1-5 ratings) and multiple-choice options. Ordinal range results were analyzed by aggregating responses 1 + 2 + 3 versus 4 + 5, with 5 representing the highest grade (\"extremely confident\" or \"full training\").</p><p><strong>Results: </strong>A total of 442 dermatology residents from 20 countries replied. These participants reported receiving less comprehensive training in supportive oncodermatology (only 41% receiving complete training) compared to immunodermatology (75%), cutaneous oncology (75%), dermoscopy (64%), and dermatologic surgery (50%). Only 17% of the residents reported feeling confident in managing the dermatological toxicities associated with anticancer treatments. Residents also indicated receiving less education regarding toxicities related to endocrine therapies (28%). In particular, lower levels of competence were reported in managing nail, hair, and oral toxicities. A significant majority of residents (98%) deemed it essential to enhance training in dermatological toxicities associated with anticancer therapies during their oncology residency.</p><p><strong>Conclusion: </strong>The RESCUE study represents the first project assessing residents' education in supportive oncodermatology. To enable future generations of dermatologists to provide enhanced care for cancer patients, supportive oncodermatology training should be integrated in residency programs worldwide, corresponding to training in other subspecialties. A more practical approach should also be incorporated, including extended training in hair, nail, and oral toxicities, enhancing the competencies of dermatology residents in all countries.</p>","PeriodicalId":22046,"journal":{"name":"Supportive Care in Cancer","volume":"33 5","pages":"412"},"PeriodicalIF":2.8,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144032373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}